PITANGO INTERNATIONAL MC 2019 LTD.

Thesis

Pitango Venture Capital, established in 1993, is Israel's largest and longest-standing venture capital fund, managing over $3 billion in assets. With a dual focus on Israel and Silicon Valley, Pitango invests globally in visionary entrepreneurs across various stages, from seed to Series B, with a particular emphasis on Series A rounds for Israeli startups. The firm employs a multi-fund strategy, including Pitango First (seed/early-stage), Pitango Growth (growth-stage), and Pitango HealthTech (health tech sector). Their investment thesis centers on deep technology and innovation, with key sectors including generative AI, cybersecurity, quantum computing, TransitTech, fintech, DevOps, cloud infrastructure, e-commerce, digital health, medical devices, diagnostics, foodtech, ag-tech, biotech, and life sciences. Pitango typically takes larger stakes in 15-25 core positions per fund, reserving 40-50% for follow-on rounds. Recent fundraising includes $300 million for Pitango First and Pitango HealthTech. Check sizes for seed funds start at approximately $5 million, ranging up to $10 million for some partners.

Related lists

• Seed-stage AI investors
• Seed-stage Developer Tools investors
• Seed-stage Fintech investors